Vitamin D may mediate immunomodulatory effects in patients with inflammatory bowel disease (IBD). The relationships between disease activity and circulating levels of total, free, and bioavailable 25(OH) vitamin D (25(OH)D) are poorly defined. The aim of this study was to measure circulating components of the vitamin D axis in patients with IBD and healthy controls and to correlate these with markers of disease activity, adjusting for potential confounders.
|Pages (from-to)||2634 - 2643|
|Number of pages||10|
|Journal||Inflammatory Bowel Diseases|
|Publication status||Published - 2013|